
Episode 078: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - Part 2
The Fellow on Call: The Heme/Onc Podcast
00:00
Exploring Treatment Strategies in Relapsed DLBCL
This chapter explores the latest treatment strategies for relapsed diffuse large B-cell lymphoma, focusing on agents like polotuzumab and tafacetamab. The effectiveness of combination therapies and newer agents, along with their implications in post-CAR-T treatment, are critically analyzed.
Transcript
Play full episode